Longevity medicine under scrutiny after Greek pop star’s death
The death of a 52-year-old Greek pop star undergoing experimental anti-aging therapies has triggered scrutiny of Europe’s loosely regulated longevity medicine sector. Authorities in Greece and Brussels are now asking questions the industry has avoided for years.
